Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros

Medicinas Complementares
Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Vet J ; 265: 105551, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-33129555

RESUMO

A commercial Aspergillus galactomannan antigen (GMA) enzyme linked immunosorbent assay (ELISA) is used to support a diagnosis of systemic aspergillosis in dogs. In human patients, false positive results have been associated with administration of medications derived from molds. We sought to determine the effect of administration of a commercially available oral probiotic nutraceutical that contained Aspergillus-derived ingredients on serum and urine Aspergillus GMA levels in dogs by conducting a prospective, cross-over study. Galactomannan index (GMI) was measured on the solubilized probiotic nutraceutical and was positive (GMI ≥ 0.5) with a mean of 7.91. Serum and urine galactomannan indices were measured in 10 healthy dogs before (day 0) and after 1 week (day 7) of probiotic nutraceutical administration, then again 2 weeks after the probiotic nutraceutical was discontinued (day 21). Median (range) serum GMI were 0.19 (0.08-0.62), 0.22 (0.07-1.15) and 0.17 (0.14-0.63) at day 0, 7 and 21, respectively. Two of 10 dogs developed positive GMI (≥0.5) results after probiotic nutraceutical administration; however, no significant changes were noted over the study period. Median (range) urine GMI results were 0.06 (0.04-0.22), 0.07 (0.05-0.41) and 0.06 (0.03-0.16) at day 0, 7 and 21, respectively. A trend towards an increase urine GMI was noted between day 0 and 7 (P = 0.18), and decrease was noted between day 7 and 21 (P = 0.09). Administration of probiotics containing Aspergillus-derived ingredients to dogs did not reliably result in elevated Aspergillus GMA levels.


Assuntos
Antígenos de Fungos/análise , Aspergilose/veterinária , Aspergillus/imunologia , Doenças do Cão/microbiologia , Mananas/imunologia , Probióticos/administração & dosagem , Animais , Antígenos de Fungos/sangue , Antígenos de Fungos/urina , Aspergilose/diagnóstico , Suplementos Nutricionais/microbiologia , Doenças do Cão/diagnóstico , Cães , Ensaio de Imunoadsorção Enzimática/veterinária , Feminino , Galactose/análogos & derivados , Masculino
2.
Mycoses ; 61(12): 931-937, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30107071

RESUMO

BACKGROUND: Screening for Aspergillus (Asp-AG) and Candida antigen (Ca-AG) with immunoassays is established for stem cell recipients at high risk for invasive fungal infections (IFI). While parenteral nutrition (PN) will be applied in case of complications leading to insufficient alimentation, piperacillin-tazobactam (TZP) is started at the onset of febrile neutropenia. OBJECTIVES: The aim of this study was to investigate drug-laboratory interactions between PN and TZP and both immunoassays which could affect the specificity of the assays and lead to the false assumption of an IFI. METHODS: Batches of TZP and PN were tested with both assays in vitro. In total, 380 samples of 83 batches were analysed. RESULTS: None of the examined preparations were tested positive with Asp-AG assay. Measurable amounts of Ca-AG were detected in a lipid emulsion, two different trace element supplements, a fat-soluble vitamin preparation and all tested brands of TZP. CONCLUSIONS: We conclude that false positivity of Asp-AG assay due to TZP and PN does not occur. Cross reactions with Ca-AG assay have been detected in some preparations. The in vivo relevance of Ca-AG positivity has to be reviewed in further studies considering an effect of dilution. Physicians should be aware of a possible cross reaction with Ca-AG assays which could lead to false-positive results.


Assuntos
Antibacterianos/química , Antígenos de Fungos/análise , Aspergillus/química , Candida/química , Soluções de Nutrição Parenteral/química , Combinação Piperacilina e Tazobactam/química , Inibidores de beta-Lactamases/química , Candidíase Invasiva/diagnóstico , Reações Falso-Positivas , Humanos , Aspergilose Pulmonar Invasiva/diagnóstico , Testes Sorológicos/métodos
3.
J Appl Microbiol ; 103(5): 1669-80, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17953578

RESUMO

AIMS: Pathogenicity of Exobasidium vexans, causal agent of blister blight of tea, was studied in 30 commercially cultivated tea varieties by analysing the antigenic patterns of host and pathogen using immunological techniques. METHODS AND RESULTS: Whole plant inoculation of tea varieties with E. vexans showed that T-78 and T-17/1/54 were most susceptible and most resistant respectively. Antigen preparations from tea varieties, pathogen, nonpathogen (Fusarium oxysporum) and of nonhosts (Glycine max, Leucaena leucocephala and Oryza sativa) were compared by indirect enzyme-linked immunosorbent assay and dot-immunobinding assay using polyclonal antibodies raised against the pathogen, nonpathogen, susceptible and resistant tea varieties. Cross-reactive antigens (CRA) were found among susceptible varieties and E. vexans isolates but not in resistant varieties, nonhosts or nonpathogen. Indirect staining of antibodies using fluorescein isothiocyanate indicated CRA were concentrated mainly around epidermal and mesophyll cells in compatible host (T-78). This was substantiated by ultrastructural studies using gold-labelled antibodies through transmission electron microscopy which showed specific localization in the chloroplasts and host cytoplasm. CONCLUSION: Pathogenicity of E. vexans to different tea varieties is therefore related to the level of antigenic similarity between host and pathogen. SIGNIFICANCE AND IMPACT OF THE STUDY: Immunological methods proved to be valuable in screening commercially cultivated tea varieties against E. vexans.


Assuntos
Antígenos/análise , Basidiomycota/imunologia , Camellia sinensis/imunologia , Microbiologia de Alimentos , Doenças das Plantas/microbiologia , Chá , Animais , Anticorpos Antifúngicos/imunologia , Anticorpos Antifúngicos/isolamento & purificação , Antígenos de Fungos/análise , Antígenos de Plantas/análise , Basidiomycota/patogenicidade , Reações Cruzadas , Ensaio de Imunoadsorção Enzimática/métodos , Imunofluorescência , Imunodifusão , Microscopia Eletrônica de Transmissão , Micologia/métodos , Planticorpos/imunologia , Planticorpos/isolamento & purificação , Coelhos
4.
Clin Exp Allergy ; 35(10): 1272-8, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16238785

RESUMO

BACKGROUND: Growing up on a farm and an anthroposophic lifestyle are associated with a lower prevalence of allergic diseases in childhood. This might be related to increased inhalatory exposure to microbial agents. OBJECTIVE: To assess the association between microbial agents in house dust and atopic wheeze in farm children, Steiner school children and reference children. METHODS: Levels of bacterial endotoxin, fungal beta(1,3)-glucans and fungal extracellular polysaccharides (EPS) in mattress and living room floor dust were measured in a population of 270 atopic (=Phadiatop-positive) children with self-reported wheezing, including 168 current atopic wheezers, and 441 non-atopic, non-symptomatic controls. These children were selected from a cross-sectional study in five European countries. RESULTS: In the study population as a whole, average levels of mattress dust endotoxin, EPS and glucans were slightly (1.1-1.2-fold; P<0.10) higher in control children than in atopic wheezers. Atopic wheeze was related to mattress levels of endotoxin, EPS and glucans in farm and farm-reference children. However, when adjusting for group (farm vs. farm-reference children), the associations became non-significant whereas the group effect remained. No associations between atopic wheeze and microbial agents were observed in Steiner and Steiner-reference children. For current atopic wheeze, the farm effect became non-significant after adjustment for microbial agent levels. CONCLUSION: Not only bacterial endotoxin but also mould components might offer some protection against atopic wheeze in children. However, the protective effect of being raised on a farm was largely unexplained by the mattress microbial agent levels measured in this study.


Assuntos
Agricultura , Alérgenos/análise , Poeira/análise , Hipersensibilidade Respiratória/prevenção & controle , Sons Respiratórios/etiologia , Adolescente , Poluição do Ar em Ambientes Fechados/análise , Antígenos de Fungos/análise , Leitos , Criança , Pré-Escolar , Estudos Transversais , Endotoxinas/análise , Europa (Continente)/epidemiologia , Feminino , Habitação , Humanos , Exposição por Inalação/análise , Masculino , Polissacarídeos/análise , Hipersensibilidade Respiratória/epidemiologia , Hipersensibilidade Respiratória/etiologia , Instituições Acadêmicas , beta-Glucanas/análise
5.
J Eukaryot Microbiol ; 45(3): 284-9, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9627988

RESUMO

Rats exposed to Pneumocystis carinii mount antibody responses to a broad band migrating on western blot with an apparent molecular weight of 45-55 kDa. One antigen within this band, designated p55, is uniformly recognized by P. carinii exposed rats. Although the gene encoding the p55 antigen had been previously cloned, the location of this antigen within the organism was unknown. Prior attempts to localize the protein were unsuccessful. A monospecific polyclonal antiserum raised against a carboxyl-terminal 15-oligomer peptide yielded specific reactivity with a single 55 kDa band on a western blot of P. carinii. Using this antiserum, little to no reactivity could be detected with P. carinii organisms by immunofluorescence assay (IFA). However, zymolyase treatment of P. carinii dramatically increased the intensity and proportion of organisms reactive by IFA. Zymolyase, an enzyme with beta-1,3 glucanase activity, has previously been shown to remove the electron dense outer layer of the P. carinii cell wall, exposing an electron lucent layer. Immunoelectron microscopy performed on zymolyase treated organisms showed the majority of labeling occurs within the cell wall.


Assuntos
Antígenos de Fungos/análise , Proteínas Fúngicas/análise , Pneumocystis/imunologia , Animais , Anticorpos Antiprotozoários/imunologia , Western Blotting , Parede Celular/imunologia , Imunofluorescência , Hidrolases/metabolismo , Microscopia Imunoeletrônica , Pneumocystis/isolamento & purificação , Infecções por Pneumocystis/imunologia , Ratos , Ratos Endogâmicos Lew
6.
J Infect Dis ; 169(2): 356-68, 1994 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8106769

RESUMO

A model of primary pulmonary aspergillosis in rabbits was developed to reproduce the persistent levels of profound granulocytopenia and the histopathologic features of bronchopneumonia, vascular invasion, and hemorrhagic infarction encountered in humans. D-mannitol was detectable in bronchoalveolar lavage fluid by gas-liquid chromatography/mass spectroscopy, and galactomannan was measurable in serum by latex agglutination immunoassay. A pharmacokinetically distinctive unilamellar vesicle formulation of liposomal amphotericin B, 5 mg/kg/day intravenously, compared with high-dose conventional desoxycholate amphotericin B, 1 mg/kg/day intravenously, was more effective in preventing nephrotoxicity, increasing survival, reducing the number of viable organisms, and decreasing tissue injury due to Aspergillus organisms. Thus, D-mannitol in lavage fluid and galactomannan in serum may be useful markers of pulmonary aspergillosis, and liposomal amphotericin B was significantly more effective and safer than desoxycholate amphotericin B for treatment of pulmonary aspergillosis in profoundly granulocytopenic rabbits.


Assuntos
Agranulocitose/complicações , Anfotericina B/administração & dosagem , Aspergilose/tratamento farmacológico , Pneumopatias/tratamento farmacológico , Animais , Antígenos de Fungos/análise , Aspergilose/sangue , Aspergilose/microbiologia , Aspergillus fumigatus/patogenicidade , Biomarcadores , Líquido da Lavagem Broncoalveolar/química , Ergosterol , Galactose/análogos & derivados , Nefropatias/induzido quimicamente , Tábuas de Vida , Lipossomos , Pneumopatias/microbiologia , Mananas/sangue , Manitol , Infecções Oportunistas/tratamento farmacológico , Coelhos , Análise de Sobrevida
7.
Clin Exp Allergy ; 23(10): 812-20, 1993 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-10780887

RESUMO

The relation of house dust mite allergen levels to asthma and allergy was examined in two population samples of children aged 8-11 years in northern New South Wales. We studied 805 children in Lismore (a hot, humid, coastal region) and 770 in Moree/Narrabri (a hot, dry inland region). Respiratory symptoms were measured by questionnaire, bronchial hyperresponsiveness (BHR) by histamine inhalation test, and allergy by skin-prick tests. Current asthma was defined as the presence of both wheeze in last 12 months and BHR. Der p I levels were measured in dust from the bed and floors in the homes of 57 randomly selected children in the coastal region and of 74 inland children. Der p I levels were significantly higher by the coast (83.0 vs 11.2 microg/g, P < 0.001). House dust mite sensitivity was of similar prevalence in both regions (28.6 vs 26.4%, n.s.) but Alternaria sensitivity was higher inland (4.0 vs 15.2% P<0.001). Bronchial responsiveness was more severe in coastal children sensitized to house dust mites and in inland children who were sensitized to Alternaria. The adjusted odds ratios for current asthma in children sensitized to house dust mites were 21.3 (95% CI 10.5, 43.2) by the coast and 2.7 (95% CI 1.3, 5.4) inland, and in children sensitized to Alternaria were 3.4 (95% CI 1.3, 9.1) in the coastal region and 5.6 (95% CI 3.1, 10.1 inland. These studies suggest that high house dust mite allergen levels in a humid, subtropical region act to significantly increase bronchial responsiveness in sensitized children, and that Alternaria allergens have a similar but less potent action in a dry, rural region.


Assuntos
Alternaria/imunologia , Asma/etiologia , Clima , Poeira/efeitos adversos , Exposição Ambiental , Habitação , Ácaros/imunologia , Alérgenos/efeitos adversos , Alérgenos/análise , Animais , Antígenos de Dermatophagoides , Antígenos de Fungos/efeitos adversos , Antígenos de Fungos/análise , Asma/epidemiologia , Asma/imunologia , Austrália/epidemiologia , Hiper-Reatividade Brônquica/epidemiologia , Hiper-Reatividade Brônquica/etiologia , Hiper-Reatividade Brônquica/imunologia , Testes de Provocação Brônquica , Broncoconstritores , Gatos , Criança , Pré-Escolar , Poeira/análise , Feminino , Glicoproteínas/efeitos adversos , Glicoproteínas/análise , Histamina , Humanos , Umidade , Masculino , Pólen , Prevalência , Saúde da População Rural , Testes Cutâneos , Temperatura
8.
J Vet Intern Med ; 7(1): 40-3, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-8455182

RESUMO

Twenty-four dogs with nasal aspergillosis were treated with enilconazole (10 mg/kg bid for 7-14 days) administered topically through tubes surgically implanted into the nasal chambers. Aspergillosis was eliminated in 19 dogs over a median follow-up period of 18 months. Another dog died, but at necropsy there was no evidence of causative fungus. Two of the four dogs that were not cured had infection of periorbital soft tissues. An additional seven dogs received 6 weeks ketoconazole (5 mg/kg bid PO) and enilconazole therapy topically. Six of these dogs were disease-free over a median follow-up period of 35 months. The seventh dog responded to repeated treatment with enilconazole. Twenty-six of the 29 dogs (90%) without extranasal aspergillosis were cured.


Assuntos
Aspergilose/veterinária , Doenças do Cão/tratamento farmacológico , Imidazóis/uso terapêutico , Doenças Nasais/veterinária , Administração Intranasal , Animais , Antígenos de Fungos/análise , Aspergilose/tratamento farmacológico , Aspergillus fumigatus/imunologia , Doenças do Cão/microbiologia , Cães , Quimioterapia Combinada , Ensaio de Imunoadsorção Enzimática/veterinária , Seguimentos , Cetoconazol/uso terapêutico , Testes de Sensibilidade Microbiana/veterinária , Doenças Nasais/tratamento farmacológico , Doenças Nasais/microbiologia
9.
J Am Acad Dermatol ; 23(3 Pt 2): 602-7, 1990 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-2170480

RESUMO

Striking results were obtained with oral itraconazole therapy in two opportunistic mycoses. Of 28 patients with cryptococcal meningitis, 18 achieved complete responses, including 16 of 24 patients with acquired immunodeficiency syndrome. Other manifestations of cryptococcosis were similarly responsive. In aspergillosis 12 of 15 patients responded, including 8 of 10 immunocompromised hosts. These patients included those with invasive pulmonary disease (4/5), skeletal disease (2/2), pleural disease (1/2), and pericardial, sinus, mastoid, hepatosplenic, or nail disease (1/1). These results with itraconazole compare favorably to conventional (parenteral) therapy, and toxicity was minimal. This suggests that comparative trials are now in order.


Assuntos
Antifúngicos/uso terapêutico , Aspergilose/tratamento farmacológico , Criptococose/tratamento farmacológico , Cetoconazol/análogos & derivados , Infecções Oportunistas/tratamento farmacológico , Síndrome da Imunodeficiência Adquirida/complicações , Síndrome da Imunodeficiência Adquirida/mortalidade , Antifúngicos/efeitos adversos , Antígenos de Fungos/análise , Aspergilose/etiologia , Aspergillus/efeitos dos fármacos , Criptococose/etiologia , Cryptococcus/imunologia , Humanos , Itraconazol , Cetoconazol/efeitos adversos , Cetoconazol/uso terapêutico , Testes de Sensibilidade Microbiana , Infecções Oportunistas/etiologia , Transplante de Órgãos/efeitos adversos , Recidiva , Taxa de Sobrevida
10.
Med Dosw Mikrobiol ; 42(3-4): 143-8, 1990.
Artigo em Polonês | MEDLINE | ID: mdl-2128102

RESUMO

The aim of this study was to get insight into chemical structure and toxigenicity of antigenic preparations obtained from A. flavus Link strain isolated from industrial environment. A microbiol multiplication and an antigenic fractions preparation scheme is presented. The method proposed allows to obtain antigens from culture filtrate (APP), mycelial extract (AEM), and two subfractions obtained from AEM: supernatant--AS and precipitated--API. The strain tested did not show aflatoxigenic activity and antigenic fractions obtained were free of aflatoxin B1, B2, G1, G2 in concentrations detectable by thin-layer chromatography. A chemical composition of the antigenic fractions was tested. A content, depending on fractions, of proteins ranged from 32.0 to 74.5 micrograms/ml, of sugars from 15.0-44.5 micrograms/ml, phosphorus 0.5-1.5 micrograms/ml, and nitrogen 2.5-4.9 micrograms/ml. Toxicity of APP and AEM antigens designated for laboratory animals immunisation was also determined. The values of LD50 for APP preparation was 2.00 mg/mouse and for AEM - 2.75 mg/mouse. These data give evidence of moderate toxicity of these preparations.


Assuntos
Antígenos de Fungos/análise , Aspergillus flavus/imunologia , Eliminação de Resíduos Líquidos , Microbiologia da Água , Animais , Antígenos de Fungos/toxicidade , Carboidratos/análise , Meios de Cultura , Proteínas Fúngicas/análise , Técnicas In Vitro , Camundongos , Fósforo/análise , Polônia
11.
Sem Hop ; 53(4): 219-25, 1977 Jan 23.
Artigo em Francês | MEDLINE | ID: mdl-189435

RESUMO

Cellular immunity in 64 patients with Hodgkin's disease was studied during diagnosis before any treatment. The functional deficiency of the thymodependent lymphocyte was demonstrated in vivo by skin tests and, in vitro, by the test of inhibition of leucocyte migration to phytohemagglutininin and spontaneous rosette formation, to sheep red cells. This deficiency correlates with the clinical spread and the histological severity. The relationship between skin anergy and biological tests was found. The epicutaneous test using croton oil possesses non-specific inflammatory activity. It is negative this test is negative, skin reactivity to specific antigens is reduced. The croton tests help interpretation of skin responses to specific antigens and thus assessment of the immune state.


Assuntos
Óleo de Cróton , Doença de Hodgkin/diagnóstico , Hipersensibilidade Tardia , Adolescente , Adulto , Fatores Etários , Idoso , Antígenos de Fungos/análise , Candida albicans/imunologia , Inibição de Migração Celular , Feminino , Doença de Hodgkin/imunologia , Humanos , Reação de Imunoaderência , Imunidade Celular , Lectinas/farmacologia , Contagem de Leucócitos , Leucócitos/imunologia , Linfócitos/imunologia , Masculino , Pessoa de Meia-Idade , Testes Cutâneos , Estreptodornase e Estreptoquinase , Teste Tuberculínico
12.
Ann Microbiol (Paris) ; 126A(4): 409-20, 1975.
Artigo em Francês | MEDLINE | ID: mdl-173223

RESUMO

Studies using the morphological mutant "amycelial"--a conditional, aconidial strain of N. crassa--have revealed certain consistent functional and biochemical differences from wild type strains showing normal morphology and conidia formation. Thus it was found that the mutant strain showed an abnormal utilization of protein reserves at a time when there is extensive degradation during conidiogenesis in wild type. In addition, the mutant exhibited abnormally low oxygen consumption and free amino acid pools depressed nearly 3/4 with respect to wild type. All of these findings are consistent with earlier work linking conidiogenesis to aerobic oxidative processes and suggest that catabolic reactions particularly regarding protein breakdown may be important to conidiogenesis from the standpoint of the synthesis of new conidial proteins and for the supply of endogenous energy reserves during the process. The aconidial character of "amycelial" could be partially alleviated on solid acetate medium supplemented with amino acids, especially tryptophan or histidine. Conidiation was also induced by cyclic-AMP, even on sucrose medium. A polymer strongly antigenic in rabbits was found to be released into growth medium by the mutant but not by wild type cultures, providing a possible clue to the immediate cause of the abnormal morphology seen in "amycelial". This substance appears to be a glycopeptide containing a few hexoses and amino acids associated with polyphosphate.


Assuntos
Neurospora crassa/crescimento & desenvolvimento , Neurospora/crescimento & desenvolvimento , Esporos Fúngicos , Aminoácidos/metabolismo , Antígenos de Fungos/análise , Diferenciação Celular/efeitos dos fármacos , Parede Celular/imunologia , Parede Celular/metabolismo , AMP Cíclico/farmacologia , Galactosamina , Glicopeptídeos/análise , Glicosaminoglicanos/análise , Histidina/farmacologia , Imunoeletroforese , Mutação , Neurospora crassa/efeitos dos fármacos , Neurospora crassa/metabolismo , Consumo de Oxigênio , Fosfatos/análise , Polímeros , Proteínas/metabolismo , Esporos Fúngicos/efeitos dos fármacos , Triptofano/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA